Crimson Laureate Society
Donations to the Crimson Laureate Society enable deserving science students to make their education a reality. Most gifts made to the College of Science are under $1,000. But together they add up to millions for financial aid, academics, research, and other programs. Together we can make a difference. Recently, many donors have doubled the impact of their investments by using matching donation programs. In these cases, supporters of the college will match the gift dollar-for-dollar, doubling the donation.
For more information on Crimson Laureate Society membership and College of Science alumni events, contact Jeff Martin at martin@science.utah.edu.
Alumni Stories
Ryan Watts
Co-Founder of Denali Therapeutics, focused on cures for neurodegenerative illnesses.
Read MoreFormer Space Researcher and Analyst Pens Gripping Mystery
New mystery novel from U fiction writer
Read MoreConnor Morgan
What does a former Student Body President and Biology alum do after graduating from the U?
Read MoreThe Art and Science of Innovation: Catmull’s Story
Ed Catmull's journey from Utah to Pixar
Read MoreCarol Blair
I was given the opportunity to work as a lab assistant with Stanton and Dalrymple.
Read MoreArie Sitthichai Mobley
Better health care based on the unique genetic makeup of each individual
Read MoreGeorge Elliott
Retired U.S. Patent & Trademark Office examiner & director on the pandemic: "It will pass"
Read MoreSolving Water Shortages by Lease
Mitigating climate change: Farmers willing to lease their H20 if it makes economic sense.
Read MoreKevin Fuller to Lead Global Marketing at Nature’s Sunshine
Learn more about Nature's Sunshine's new CMO
Read MoreAndy Thliveris: Remember the Undergrads
A thankful undergrad helps make possible an endowed chair in biology
Read MoreCoal Miner’s Daughter
Denee Hayes’ holistic approach to thinking outside the mining "blast hole."
Read MoreJulia Bailey-Serres
NAS member & U alum pilots Center for Plant Cell Biology, UC Riverside
Read MoreClifford Stocks
Whether cancer or a pandemic, OncoResponse CEO knows how to grapple with an opponent
Read More